BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 16001531)

  • 1. [Monoclonal gammopathy--multiple myeloma].
    Dietzfelbinger H
    MMW Fortschr Med; 2005 Jun; 147(24):32-3, 35-6. PubMed ID: 16001531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and therapy of multiple myeloma: current aspects].
    Betticher DC; Cerny T; Fey MF
    Schweiz Med Wochenschr; 1995 Mar; 125(11):541-51. PubMed ID: 7899848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance?
    Elis A; Radnay J; Shapiro H; Itzhaky D; Manor Y; Lishner M
    Isr Med Assoc J; 2006 Dec; 8(12):840-2. PubMed ID: 17214099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma].
    Schleiffenbaum BE
    Praxis (Bern 1994); 2012 Nov; 101(24):1521-9; quiz 1530-1. PubMed ID: 23184544
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple myeloma: diagnosis and treatment.
    Nau KC; Lewis WD
    Am Fam Physician; 2008 Oct; 78(7):853-9. PubMed ID: 18841734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The CBO professional guideline 'monoclonal gammopathy' (paraproteinemia) (revision)].
    Buiting AM; Wijermans PW
    Ned Tijdschr Geneeskd; 2002 Jul; 146(30):1406-11. PubMed ID: 12174434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
    Sezer O; Heider U; Zavrski I; Possinger K
    Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsecretory multiple myeloma.
    Abdalla IA; Tabbara IA
    South Med J; 2002 Jul; 95(7):761-4. PubMed ID: 12144086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of newly diagnosed myeloma.
    Rajkumar SV; Palumbo A
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1141-56, ix-x. PubMed ID: 17996592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of paraproteinaemia.
    Cook L; Macdonald DH
    Postgrad Med J; 2007 Apr; 83(978):217-23. PubMed ID: 17403946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
    Martín P; Santón A; Bellas C
    Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the management of multiple myeloma.
    Kumar L; Verma R; Radhakrishnan VR
    Natl Med J India; 2010; 23(4):210-8. PubMed ID: 21192514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells.
    López-Corral L; Gutiérrez NC; Vidriales MB; Mateos MV; Rasillo A; García-Sanz R; Paiva B; San Miguel JF
    Clin Cancer Res; 2011 Apr; 17(7):1692-700. PubMed ID: 21325290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.
    Palumbo A; Bertola A; Musto P; Caravita T; Callea V; Nunzi M; Grasso M; Falco P; Cangialosi C; Boccadoro M
    Cancer; 2005 Oct; 104(7):1428-33. PubMed ID: 16116606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of interleukin-6 messenger RNA as malignant progression index in monoclonal gammapathy of undetermined significance].
    Mancini R; Palange M; Dionisi MG; De Angelis V; Matteocci A; Strano L
    Recenti Prog Med; 1999 Oct; 90(10):522-6. PubMed ID: 10592737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple myeloma in the elderly.
    Cohen HJ
    Clin Geriatr Med; 1985 Nov; 1(4):827-55. PubMed ID: 3913521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome.
    Avet-Loiseau H; Facon T; Daviet A; Godon C; Rapp MJ; Harousseau JL; Grosbois B; Bataille R
    Cancer Res; 1999 Sep; 59(18):4546-50. PubMed ID: 10493504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation.
    Rajkumar SV; Buadi F
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):665-80. PubMed ID: 18070712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma cell disorders in HIV-infected patients: from benign gammopathy to multiple myeloma.
    Dezube BJ; Aboulafia DM; Pantanowitz L
    AIDS Read; 2004 Jul; 14(7):372-4, 377-9. PubMed ID: 15282866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple myeloma: recognition and management.
    George ED; Sadovsky R
    Am Fam Physician; 1999 Apr; 59(7):1885-94. PubMed ID: 10208707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.